Increased plasma levels of the mature and intermediate forms of adrenomedullin in obesity
Increased plasma levels of the mature and intermediate forms of adrenomedullin in obesity
复制标题
DOI:
10.1016/j.regpep.2009.08.003
复制
发表时间:
2009-11-27
影响因子:
--
通讯作者:
Kitamura, Kazuo
中科院分区:
文献类型:
--
作者:
Nomura, Ikuo;Kato, Johji;Kitamura, Kazuo
Adrenomedullin (AM) is a cardiovascular protective peptide produced in various organs and tissues including adipose tissue. In the present study, we measured the plasma AM levels of subjects with or without obesity by two assay methods to separately evaluate the biologically active AM-NH2 and the intermediate form of AM-glycine (AM-Gly). We measured the total AM and AM-NH2 levels of plasma in 52 obese and 172 non-obese residents of a Japanese community, who received regular health check-ups and had no overt cardiovascular disease. AM-Gly values were obtained by subtracting AM-NH2 levels from those of total AM. Both the AM-NH2 and AM-Gly levels of the subjects with obesity were higher than those without obesity, and significant relationships were noted between body mass index (BMI) and the plasma levels of the two molecular forms of AM in a simple regression analysis. Moreover, the significant factors identified by multivariate analyses were BMI and serum triglyceride for AM-NH2 and diastolic blood pressure, insulin, high-density lipoprotein-cholesterol, and plasma renin activity for AM-Gly. These results suggest active roles for the two molecular forms of AM in metabolic disorders associated with obesity in subjects without overt cardiovascular disease. (C) 2009 Elsevier B.V. All rights reserved.